Human CD30 Ligand / TNFSF8 Protein, Mouse IgG2a Fc Tag, low endotoxin

Customer Reviews
Cat. No. / Size
Price
Qty
CDL-H525b-100ug
$395.00
CDL-H525b-1mg (250ug X 4)
$2615.00
ETA of in-stock products:2 business days

Product Details

  • Synonyms

    CD30-L, CD153, TNFSF8, CD30L, CD30LG, CD153 antigen, CD30 antigen ligand, CD30 Ligand

  • Source

    Human CD30 Ligand Protein, Mouse IgG2a Fc Tag (CDL-H525b) is expressed from human 293 cells (HEK293). It contains AA Gln 63 - Asp 234 (Accession # P32971-1).

    Predicted N-terminus: Glu

    Request for sequence
  • Molecular Characterization

    CD30 ligand Structure

    Other Tags and Version Biotin & Other Labeled Version

    This protein carries a mouse IgG2a Fc tag at the N-terminus.

    The protein has a calculated MW of 46.5 kDa. The protein migrates as 55-65 kDa when calibrated against Star Ribbon Pre-stained Protein Marker under reducing (R) condition (SDS-PAGE) due to glycosylation.

  • Endotoxin

    Less than 0.01 EU per μg by the LAL method / rFC method.

  • Purity

    >90% as determined by SDS-PAGE.

  • Formulation

    Lyophilized from 0.22 μm filtered solution in Tris with Glycine, Arginine and NaCl, pH7.5 with trehalose as protectant.

    Contact us for customized product form or formulation.

  • Reconstitution

    Please see Certificate of Analysis for specific instructions.

    For best performance, we strongly recommend you to follow the reconstitution protocol provided in the CoA.

  • Storage

    For long term storage, the product should be stored at lyophilized state at -20°C or lower.

    Please avoid repeated freeze-thaw cycles.

    This product is stable after storage at:

    1. -20°C to -70°C for 12 months in lyophilized state;
    2. -70°C for 3 months under sterile conditions after reconstitution.
  • ACRO Quality Management System

    1. QMS(ISO, GMP)
    2. Quality Advantages
    3. Quality Control Process

Customers Also Viewed

Performance Data

  • SDS-PAGE

    CD30 ligand SDS-PAGE

    Human CD30 Ligand Protein, Mouse IgG2a Fc Tag on SDS-PAGE under reducing (R) condition. The gel was stained with Coomassie Blue. The purity of the protein is greater than 90% (With Star Ribbon Pre-stained Protein Marker).

  • Bioactivity-ELISA

     CD30 ligand ELISA

    Immobilized Human CD30, His Tag (Cat. No. CD0-H5229) at 2 μg/mL (100 μL/well) can bind Human CD30 Ligand Protein, Mouse IgG2a Fc Tag (Cat. No. CDL-H525b) with a linear range of 0.4-25 ng/mL (QC tested).

    Protocol
  • Bioactivity-BLI

     CD30 ligand BLI

    Loaded Biotinylated Human CD30 Protein, Avitag,His Tag (Cat. No. CD0-H82E6) on SA Biosensor, can bind Human CD30 Ligand Protein, Mouse IgG2a Fc Tag (Cat. No. CDL-H525b) with an affinity constant of 114 nM as determined in BLI assay (ForteBio Octet Red96e) (Routinely tested).

    Protocol
  • Bioactivity-FACS

     CD30 ligand FACS

    FACS analysis shows that Human CD30 Ligand Protein, Mouse IgG2a Fc Tag (Cat. No. CDL-H525b) can bind to K562-CD30 cells surface CD30. The concentration of Human CD30 Ligand is 0.1 μg/mL (Routinely tested).

    Protocol
  •  CD30 ligand FACS

    FACS analysis shows that the binding of Human CD30 Ligand Protein, Mouse IgG2a Fc Tag (Cat. No. CDL-H525b) to K562-CD30 cells surface CD30 was inhibited by increasing concentration of neutralizing anti-CD30 antibody. The concentration of Human CD30 Ligand used is 0.1 μg/mL. The IC50 is 0.2064 μg/mL (Routinely tested).

    Protocol

Customer Reviews
Writing Reviews

Background

CD30 ligand (CD30L) and CD30 are interacting cellsurface glycoproteins that are members of the tumour necrosis factor (TNF) and tumour necrosis factor receptor
(TNFR) superfamilies. In humans, CD30L is expressed at high levels on activated T cells. There is conflicting evidence with regard to cell surface expression of CD30L on primary human B cells. An initial report of constitutive CD30L expression on peripheral blood B cells33 has not been substantiated.

Recent Advances

 
Drug Development Progress
  • English Name:

    Tumor necrosis factor ligand superfamily member 8

  • Category:

  • Approved Drugs:

    0 Details

  • Drugs in Clinical Trials:

    0 Details

  • Highest Development Stage:

    Preclinical

Drug Candidate Licensing
More
  • Basic Product Information
  • Product Details
  • Customers Also Viewed
  • Performance Data
  • Customer Reviews
  • Background